Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2361${count})

  • Research Grant, 2015
    Investigation of SNCA Mosaicism in Brain in Parkinson's Disease

    Objective/Rationale:             
    In most cases, the cause of Parkinson’s disease (PD) is unknown. Testing blood for genetic mutations (DNA changes) known to cause PD is usually negative, particularly...

  • Target Validation, 2015
    Utilizing Transcriptional Pathways to Enhance Mitochondrial Health in Models of Parkinson’s Disease

    Objective/Rationale:             
    Neurons of the substantia nigra are particularly vulnerable to cell death in Parkinson’s disease (PD). One potential contributing factor is dysfunction of mitochondria...

  • Target Validation, 2015
    Modulating Aging-controlling Pathways in Pre-clinical models of Parkinson’s Disease

    Objective/Rationale:             
    Because of its unknown etiology and its link to aging, Parkinson’s disease is often seen as a stochastic and pathological acceleration of aging. Using a high-content...

  • Research Grant, 2015
    Unified Dyskinesia Rating Scale: Application for FDA Designation as a Preferred Scale for Assessing Dyskinesia in Parkinson’s Disease

    Study Rationale:
    Several scales are available for the rating of dyskinesia in Parkinson’s disease, and the designation of a single preferred scale for studies of  new treatments will allow different...

  • Target Validation, 2015
    NLRP3 Inflammasome in Parkinson's Disease

    Objective/Rationale:             
    The goal of this proposal is to validate the NLRP3 inflammasome as a therapeutic target in Parkinson’s disease. Unlike circulating inflammatory mediators whose complex...

  • Research Grant, 2015
    Cell-to-Cell Transport of Alpha-Synuclein

    Study Rationale:                   
    In Parkinson’s disease, the protein alpha-synuclein changes shape, and we think it transfers around the brain. We want to see if we can recreate this in non-human...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.